Shares of Cerecor Inc. (CERC) are rising over 21% in pre-market today, after the company announced exploration of the role of an inflammatory cytokine, LIGHT, in COVID-19 patients with acute lung injury leading to Acute Respiratory Distress Syndrome.
from RTT - Before the Bell https://ift.tt/39lurZc
via IFTTT
No comments:
Post a Comment